Eclectic Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
8,062
-100
-1% -$23.3K 0.23% 58
2026
Q1
$2M Sell
8,162
-188
-2% -$43.8K 0.26% 60
2025
Q4
$1.73M Buy
8,350
+66
+0.8% +$13.1K 0.27% 61
2025
Q3
$1.54M Sell
8,284
-237
-3% -$40.6K 0.28% 55
2025
Q2
$1.3M Sell
8,521
-31
-0.4% -$4.76K 0.28% 61
2025
Q1
$1.42M Buy
8,552
+223
+3% +$34.9K 0.38% 55
2024
Q4
$1.2M Buy
8,329
+93
+1% +$14.4K 0.36% 55
2024
Q3
$1.33M Buy
8,236
+97
+1% +$15.5K 0.53% 35
2024
Q2
$1.19M Sell
8,139
-407
-5% -$60.5K 0.53% 32
2024
Q1
$1.35M Sell
8,546
-886
-9% -$141K 0.62% 31
2023
Q4
$1.48M Buy
9,432
+270
+3% +$41.4K 0.71% 28
2023
Q3
$1.43M Sell
9,162
-144
-2% -$23.8K 0.73% 28
2023
Q2
$1.54M Sell
9,306
-614
-6% -$99.1K 0.76% 26
2023
Q1
$1.54M Buy
9,920
+477
+5% +$77K 0.79% 28
2022
Q4
$1.67M Buy
9,443
+9
+0.1% +$1.55K 0.81% 31
2022
Q3
$1.54M Buy
9,434
+49
+0.5% +$8.29K 1.01% 20
2022
Q2
$1.67M Sell
9,385
-241
-3% -$42.9K 1.12% 20
2022
Q1
$1.71M Buy
9,626
+268
+3% +$45.6K 1.09% 21
2021
Q4
$1.6M Buy
9,358
+305
+3% +$49.9K 1.02% 20
2021
Q3
$1.46M Buy
9,053
+270
+3% +$46.1K 1.07% 20
2021
Q2
$1.45M Buy
8,783
+191
+2% +$31.6K 1.09% 19
2021
Q1
$1.41M Buy
8,592
+151
+2% +$24.4K 1.17% 18
2020
Q4
$1.33M Buy
+8,441
New +$1.25M 1.26% 19

Other funds holding JNJ

Eclectic Associates's JNJ Position: Q2 2026 in Review

Eclectic Associates reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q2 2026, selling an estimated $23.3K and leaving 8,062 shares worth $2.05M. The position accounts for 0.23% of the portfolio, ranked #58.

Eclectic Associates first reported a position in JNJ in Q4 2020 and has held it in 23 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Eclectic Associates held 8,062 shares of Johnson & Johnson worth $2.05M as of Q2 2026.
  • Eclectic Associates sold 100 Johnson & Johnson shares in Q2 2026, an estimated $23.3K.
  • Johnson & Johnson made up 0.23% of Eclectic Associates's portfolio in Q2 2026, its #58 holding.
  • Eclectic Associates first reported a position in Johnson & Johnson in Q4 2020 and has held it in 23 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Eclectic Associates's 13F filing for Q2 2026, filed 7 Jul 2026.